Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.00 +0.16 (+4.17%)
At close: Oct 2, 2026 · 4:00 PM EDT

Camp4 Therapeutics (CAMP) Cash from Investing Activities (2023 - 2026)

Updated

Camp4 Therapeutics' Cash from Investing Activities came in at -$129,000 for Q2 2026.

Analysis

Camp4 Therapeutics (CAMP) Cash from Investing Activities (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Camp4 Therapeutics reported Cash from Investing Activities of -$93,000; for FY2025, it came in at -$243,000.

  • Going back by year, Cash from Investing Activities was -$441,000 in FY2024 and -$678,000 in FY2023.
  • The Q2 2026 figure represents the lowest quarterly Cash from Investing Activities since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Camp4 Therapeutics 207.71 Mn 207.71 Mn - -129,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -129,000.00
Sep 30, 2025 36,000.00
Mar 31, 2025 -279,000.00
Dec 31, 2024 -263,000.00
Jun 30, 2024 -163,000.00
Mar 31, 2024 -15,000.00
Dec 31, 2023 -243,000.00
API Access

Camp4 Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=CAMP&period=max&api_key=YOUR_API_KEY